SCAI and CRT launch partnership to expand innovation and training in interventional cardiology

The Society for Cardiovascular Angiography & Interventions (SCAI) and Cardiovascular Research Technologies (CRT) today announce a new collaboration to elevate the field of interventional cardiology through shared education programming, legislative activities, and future research initiatives.

As part of the collaboration, CRT is offering SCAI members discounted registration for CRT 2026, where the two organizations will also offer joint education. Supporting SCAI and CRT's strong advocacy focus, SCAI will coordinate an annual Day on the Hill legislative event tied to the CRT meeting in Washington, DC. Over the long term, SCAI and CRT will explore collaborative research opportunities, including novel registry and clinical trial programs. 

"Collaboration is key to the future of medicine-interventional cardiology in particular-and SCAI's commitment to improve outcomes for our patients. SCAI and CRT share a common mission to advance interventional cardiology through collaboration, science, advocacy, regulatory policies, and education. While coming at these goals from different vantage points, our new partnership reflects the growing alignment in vision, and SCAI looks forward to the many benefits of working together with CRT," said Srihari S. Naidu, MD, MSCAI, president of SCAI.

The partnership will be guided by the SCAI–CRT Task Force, composed of representatives from both organizations who will identify and coordinate collaborative opportunities. In support of these initiatives, SCAI will form a working group to evaluate research projects, including the development of registries and clinical trials, to be submitted by SCAI, its members, and CRT's research network. CRT will provide core lab services, and SCAI and CRT will work jointly to secure external funding.

"Together, we will create new avenues to engage physicians, foster innovation, and build programs that address the clinical and policy challenges shaping our field. By combining our strengths, we can accelerate investigator-led research, expand professional development, and ultimately deliver better care for patients," said J. Dawn Abbott, MD, MSCAI, chair of the SCAI–CRT Partnership Task Force and president-elect of SCAI.

"Through CRT's collaboration with SCAI, we're expanding the impact of both organizations. This partnership allows us to connect clinical science, advocacy, and education in ways that will drive innovation and bring together experts from across cardiovascular medicine. Our shared vision is to strengthen the pipeline of research, inspire the next generation of interventionalists, and ensure that patients everywhere benefit from the rapid progress being made in the interventional lab," said Ron Waksman, MD, MSCAI, chair of the CRT meeting.